Vinod Khosla Says AI Is Creating a ‘Hyperabundance’ of New Drugs, but Testing Is Still ‘18th-Century’
benzinga_article·- Venture capitalist Vinod Khosla stated that artificial intelligence is driving a hyperabundance of new drugs, while conventional testing methods remain outdated. - He highlighted biotechnology company Vivodyne for evaluating drugs using living human tissues at an industrial scale to replace animal testing. - Major industry players like Anthropic, Takeda, Nvidia, and Eli Lilly are increasingly integrating artificial intelligence into drug discovery and clinical research.